Unknown

Dataset Information

0

Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience.


ABSTRACT: BACKGROUND:Venoarterial extracorporeal membrane oxygenation (VA-ECMO) can be a rescue therapy for patients in cardiogenic shock or in refractory cardiac arrest. After cannulation, vasoplegia and cardiac depression are frequent. In literature, there are conflicting data on inotropic therapy in these patients. METHODS:Analysis of a retrospective registry of all patients treated with VA-ECMO in a university hospital center between October 2010 and December 2018 for cardiogenic shock or extracorporeal cardiopulmonary resuscitation (eCPR) with a focus on individual early inotropic therapy. RESULTS:A total of 231 patients (age 58.6 ± 14.3, 29.9% female, 58% eCPR, in-house survival 43.7%) were analyzed. Of these, 41.6% received no inotrope therapy within the first 24 h (survival 47.9%), 29.0% received an inodilator (survival 52.2%), and 29.0% received epinephrine (survival 25.0%). Survival of patients with epinephrine was significantly worse compared to other patient groups when evaluating 30-day survival (p = 0.034/p = 0.005) and cumulative incidence of in-hospital death (p = 0.001). In a multivariate logistic regression analysis, treatment with epinephrine was associated with mortality in the whole cohort (OR 0.38, p = 0.011) as well as after propensity score matching (OR 0.24, p = 0.037). We found no significant differences between patients with inodilator treatment and those without. CONCLUSION:Early epinephrine therapy within the first 24 h after cannulation for VA-ECMO was associated with poor survival compared to patients with or without any inodilator therapy. Until randomized data are available, epinephrine should be avoided in patients on VA-ECMO.

SUBMITTER: Zotzmann V 

PROVIDER: S-EPMC6751670 | biostudies-other | 2019 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience.

Zotzmann Viviane V   Rilinger Jonathan J   Lang Corinna N CN   Kaier Klaus K   Benk Christoph C   Duerschmied Daniel D   Biever Paul M PM   Bode Christoph C   Wengenmayer Tobias T   Staudacher Dawid L DL  

Critical care (London, England) 20190918 1


<h4>Background</h4>Venoarterial extracorporeal membrane oxygenation (VA-ECMO) can be a rescue therapy for patients in cardiogenic shock or in refractory cardiac arrest. After cannulation, vasoplegia and cardiac depression are frequent. In literature, there are conflicting data on inotropic therapy in these patients.<h4>Methods</h4>Analysis of a retrospective registry of all patients treated with VA-ECMO in a university hospital center between October 2010 and December 2018 for cardiogenic shock  ...[more]

Similar Datasets

| S-EPMC6034480 | biostudies-other
2024-10-15 | GSE182609 | GEO
2019-12-31 | GSE93101 | GEO
2024-10-15 | GSE182608 | GEO
2024-10-15 | GSE182600 | GEO
| S-EPMC3876455 | biostudies-literature
| S-EPMC5296266 | biostudies-literature
| S-EPMC8465743 | biostudies-literature
| S-EPMC4548884 | biostudies-literature
| S-EPMC8318444 | biostudies-literature